Filter
3860
Filtered Results: 3860
Text search:
drug
distribution
Featured
Recommendations
316
New Publications
1153
Language
Document type
No document type
2462
Studies & Reports
589
Guidelines
437
Manuals
142
Strategic & Response Plan
117
Training Material
39
Fact sheets
39
Situation Updates
22
Infographics
8
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
117
Uganda
106
Ethiopia
101
Nigeria
96
South Africa
82
Sierra Leone
76
Liberia
76
Nepal
73
Western and Central Europe
73
Malawi
71
Tanzania
67
Zambia
61
Myanmar / Burma
59
Ghana
58
Bangladesh
55
Rwanda
54
Latin America and the Carribbean
54
Africa
50
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Cambodia
31
Lesotho
30
South–East Asia Region
27
Asia
26
Senegal
25
Botswana
23
Congo, Democratic Republic of
20
Indonesia
20
Russia
20
Burkina Faso
19
Mozambique
19
East and Southern Africa
16
Syria
15
Haiti
14
Eswatini/ Swaziland
13
USA
11
South Sudan
11
West and Central Africa
11
Albania
11
Cameroon
10
Thailand
10
Middle East and North Africa
10
Benin
9
Brazil
9
Guinea
8
Pakistan
8
Germany
8
Colombia
8
Eastern Europe and Central Asia
8
Venezuela
8
Tajikistan
8
Sudan
7
Georgia
7
Moldova
6
Vietnam
6
Iraq
5
Afghanistan
5
North Macedonia
5
Laos
5
China
4
Argentina
4
Sri Lanka
4
Paraguay
4
Armenia
4
Morocco
3
Jordan
3
Lebanon
3
Turkey
3
Papua New Guinea
3
Peru
3
Bolivia
3
Western Pacific Region
3
Bhutan
3
Timor Leste/ East Timor
3
Spain
3
Central African Republic
2
El Salvador
2
Libya
2
Madagascar
2
Chile
2
Yemen
2
Fiji
2
Mongolia
2
Southern Africa
2
Iran
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Gabon
2
Tunisia
2
United Kingdom
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Egypt
1
Chad
1
Ireland
1
Serbia
1
Hungary
1
Honduras
1
Greece
1
Angola
1
Mexico
1
Palestine
1
North Korea
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1629
Clinical Guidelines
335
Public Health
205
Women & Child Health
140
Key Resources
76
Pharmacy & Technologies
57
Capacity Building
48
Annual Report MEDBOX
1
Toolboxes
HIV
426
Mental Health
324
TB
296
AMR
185
NTDs
155
COVID-19
150
Pharmacy
143
Rapid Response
69
Caregiver
62
Planetary Health
59
NCDs
58
Ebola
49
Refugee
48
Disability
45
Conflict
44
Global Health Education
40
Health Financing Toolbox
26
Natural Hazards
20
Specific Hazards
15
Cholera
14
Polio
14
Zika
14
Social Ethics
7
Health Financing
1
The article explores the underlying factors influencing unhealthy diets and sedentary lifestyles among adolescents in Kilifi County, Kenya. Using a qualitative approach, the study involved interviews and focus group discussions with adolescents, stakeholders, and young adults. Key findings include a...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a significant portion of global mortality, particular...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an implementation plan.
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularly during the COVID-19 pandemic. It highlights regio...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium ...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). The focus of this module is on building the knowledge and skills of the Multi-Purpose Workers (MPW) in
undertaking Population Based Screening, identifi ca...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris...
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial globa...
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds upon the work of the International Study of Asthma and Allergies in Childhood (ISAAC) and The International Union Against Tuberculosis and Lung Disease (T...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
